TCL Archive NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face January 16, 1987
TCL Archive NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed July 9, 1976
TCL Archive Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB September 28, 1979
TCL Archive Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products June 3, 2011
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012